IDEXX Laboratories, Inc. (0J8P.L)
USD 470.48
(-0.04%)
USD 470.48
(-0.04%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 845.04 Million USD | 24.44% |
| 2022 | 679.08 Million USD | -8.83% |
| 2021 | 744.84 Million USD | 28.03% |
| 2020 | 581.77 Million USD | 36.02% |
| 2019 | 427.72 Million USD | 13.44% |
| 2018 | 377.03 Million USD | 43.28% |
| 2017 | 263.14 Million USD | 18.51% |
| 2016 | 222.04 Million USD | 15.6% |
| 2015 | 192.07 Million USD | 5.59% |
| 2014 | 181.9 Million USD | -3.14% |
| 2013 | 187.8 Million USD | 5.35% |
| 2012 | 178.26 Million USD | 10.19% |
| 2011 | 161.78 Million USD | 14.51% |
| 2010 | 141.28 Million USD | 15.59% |
| 2009 | 122.22 Million USD | 5.21% |
| 2008 | 116.16 Million USD | 23.57% |
| 2007 | 94.01 Million USD | 0.36% |
| 2006 | 93.67 Million USD | 19.71% |
| 2005 | 78.25 Million USD | -0.1% |
| 2004 | 78.33 Million USD | 37.21% |
| 2003 | 57.09 Million USD | 25.78% |
| 2002 | 45.38 Million USD | 20.65% |
| 2001 | 37.62 Million USD | 2.7% |
| 2000 | 36.63 Million USD | 12.37% |
| 1999 | 32.6 Million USD | 314.47% |
| 1998 | -15.2 Million USD | 27.96% |
| 1997 | -21.1 Million USD | -164.72% |
| 1996 | 32.6 Million USD | 51.63% |
| 1995 | 21.5 Million USD | 61.65% |
| 1994 | 13.3 Million USD | 37.11% |
| 1993 | 9.7 Million USD | 97.96% |
| 1992 | 4.9 Million USD | 53.13% |
| 1991 | 3.2 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 203.29 Million USD | -13.7% |
| 2024 Q1 | 235.57 Million USD | 21.11% |
| 2024 Q3 | 232.84 Million USD | 14.53% |
| 2023 Q1 | 214.05 Million USD | 24.3% |
| 2023 FY | 845.04 Million USD | 24.44% |
| 2023 Q4 | 194.52 Million USD | -8.34% |
| 2023 Q3 | 212.23 Million USD | -5.35% |
| 2023 Q2 | 224.23 Million USD | 4.76% |
| 2022 Q1 | 193.96 Million USD | 19.16% |
| 2022 Q3 | 180.93 Million USD | 37.1% |
| 2022 Q2 | 131.97 Million USD | -31.96% |
| 2022 Q4 | 172.2 Million USD | -4.83% |
| 2022 FY | 679.08 Million USD | -8.83% |
| 2021 Q3 | 175.23 Million USD | -13.5% |
| 2021 Q1 | 204.25 Million USD | 16.86% |
| 2021 Q2 | 202.58 Million USD | -0.82% |
| 2021 Q4 | 162.77 Million USD | -7.11% |
| 2021 FY | 744.84 Million USD | 28.03% |
| 2020 Q1 | 111.82 Million USD | 23.57% |
| 2020 FY | 581.77 Million USD | 36.02% |
| 2020 Q2 | 148.94 Million USD | 33.19% |
| 2020 Q3 | 146.21 Million USD | -1.83% |
| 2020 Q4 | 174.79 Million USD | 19.54% |
| 2019 FY | 427.72 Million USD | 13.44% |
| 2019 Q1 | 102.68 Million USD | 19.9% |
| 2019 Q3 | 108.83 Million USD | -13.42% |
| 2019 Q2 | 125.7 Million USD | 22.42% |
| 2019 Q4 | 90.49 Million USD | -16.85% |
| 2018 Q2 | 108.69 Million USD | 21.51% |
| 2018 Q1 | 89.45 Million USD | 133.82% |
| 2018 Q3 | 93.25 Million USD | -14.21% |
| 2018 FY | 377.03 Million USD | 43.28% |
| 2018 Q4 | 85.63 Million USD | -8.16% |
| 2017 Q3 | 70.51 Million USD | -17.39% |
| 2017 FY | 263.14 Million USD | 18.51% |
| 2017 Q4 | 38.25 Million USD | -45.74% |
| 2017 Q2 | 85.35 Million USD | 23.67% |
| 2017 Q1 | 69.01 Million USD | 31.79% |
| 2016 Q4 | 52.36 Million USD | -7.24% |
| 2016 Q2 | 67.2 Million USD | 46.03% |
| 2016 Q3 | 56.45 Million USD | -15.99% |
| 2016 Q1 | 46.01 Million USD | 3.77% |
| 2016 FY | 222.04 Million USD | 15.6% |
| 2015 Q1 | 46.59 Million USD | 79.48% |
| 2015 Q4 | 44.34 Million USD | 0.28% |
| 2015 Q3 | 44.22 Million USD | -22.3% |
| 2015 Q2 | 56.91 Million USD | 22.14% |
| 2015 FY | 192.07 Million USD | 5.59% |
| 2014 Q1 | 46.58 Million USD | 7.69% |
| 2014 FY | 181.9 Million USD | -3.14% |
| 2014 Q4 | 25.96 Million USD | -50.21% |
| 2014 Q3 | 52.14 Million USD | -8.87% |
| 2014 Q2 | 57.21 Million USD | 22.82% |
| 2013 Q2 | 53.99 Million USD | 20.36% |
| 2013 Q4 | 43.25 Million USD | -5.32% |
| 2013 Q3 | 45.68 Million USD | -15.38% |
| 2013 FY | 187.8 Million USD | 5.35% |
| 2013 Q1 | 44.86 Million USD | 3.47% |
| 2012 Q3 | 42.85 Million USD | -16.49% |
| 2012 Q4 | 43.35 Million USD | 1.17% |
| 2012 Q1 | 40.74 Million USD | 7.19% |
| 2012 FY | 178.26 Million USD | 10.19% |
| 2012 Q2 | 51.31 Million USD | 25.95% |
| 2011 Q1 | 36.61 Million USD | 0.66% |
| 2011 Q2 | 48.65 Million USD | 32.9% |
| 2011 FY | 161.78 Million USD | 14.51% |
| 2011 Q4 | 38.01 Million USD | -1.29% |
| 2011 Q3 | 38.5 Million USD | -20.86% |
| 2010 Q1 | 33.02 Million USD | 6.7% |
| 2010 Q2 | 37.19 Million USD | 12.62% |
| 2010 Q4 | 36.37 Million USD | 4.83% |
| 2010 Q3 | 34.69 Million USD | -6.72% |
| 2010 FY | 141.28 Million USD | 15.59% |
| 2009 FY | 122.22 Million USD | 5.21% |
| 2009 Q2 | 33.66 Million USD | 29.14% |
| 2009 Q4 | 30.95 Million USD | -1.86% |
| 2009 Q3 | 31.53 Million USD | -6.33% |
| 2009 Q1 | 26.07 Million USD | 10.68% |
| 2008 Q2 | 39.36 Million USD | 42.88% |
| 2008 Q4 | 23.55 Million USD | -8.34% |
| 2008 FY | 116.16 Million USD | 23.57% |
| 2008 Q1 | 27.55 Million USD | 7.92% |
| 2008 Q3 | 25.69 Million USD | -34.71% |
| 2007 FY | 94.01 Million USD | 0.36% |
| 2007 Q4 | 25.52 Million USD | -1.04% |
| 2007 Q3 | 25.79 Million USD | 19.07% |
| 2007 Q2 | 21.66 Million USD | 3.03% |
| 2007 Q1 | 21.02 Million USD | -14.77% |
| 2006 Q2 | 25.78 Million USD | 41.08% |
| 2006 Q1 | 18.27 Million USD | -8.76% |
| 2006 FY | 93.67 Million USD | 19.71% |
| 2006 Q4 | 24.67 Million USD | -1.13% |
| 2006 Q3 | 24.95 Million USD | -3.21% |
| 2005 FY | 78.25 Million USD | -0.1% |
| 2005 Q3 | 20.6 Million USD | 3.37% |
| 2005 Q1 | 17.69 Million USD | 4.46% |
| 2005 Q4 | 20.02 Million USD | -2.8% |
| 2005 Q2 | 19.93 Million USD | 12.68% |
| 2004 Q2 | 23.91 Million USD | 34.39% |
| 2004 Q4 | 16.93 Million USD | -14.02% |
| 2004 FY | 78.33 Million USD | 37.21% |
| 2004 Q1 | 17.79 Million USD | 43.88% |
| 2004 Q3 | 19.69 Million USD | -17.62% |
| 2003 Q4 | 12.36 Million USD | -22.59% |
| 2003 Q2 | 16.69 Million USD | 38.37% |
| 2003 FY | 57.09 Million USD | 25.78% |
| 2003 Q1 | 12.06 Million USD | -5.45% |
| 2003 Q3 | 15.97 Million USD | -4.3% |
| 2002 FY | 45.38 Million USD | 20.65% |
| 2002 Q3 | 12.48 Million USD | -3.71% |
| 2002 Q1 | 7.18 Million USD | -26.89% |
| 2002 Q4 | 12.75 Million USD | 2.19% |
| 2002 Q2 | 12.96 Million USD | 80.43% |
| 2001 Q4 | 9.82 Million USD | -3.81% |
| 2001 FY | 37.62 Million USD | 2.7% |
| 2001 Q1 | 7.6 Million USD | -22.37% |
| 2001 Q2 | 9.96 Million USD | 30.98% |
| 2001 Q3 | 10.21 Million USD | 2.52% |
| 2000 Q4 | 9.8 Million USD | 5.74% |
| 2000 FY | 36.63 Million USD | 12.37% |
| 2000 Q3 | 9.26 Million USD | -2.72% |
| 2000 Q2 | 9.52 Million USD | 18.6% |
| 2000 Q1 | 8.03 Million USD | -9.73% |
| 1999 Q4 | 8.9 Million USD | 5.95% |
| 1999 FY | 32.6 Million USD | 314.47% |
| 1999 Q2 | 8 Million USD | 9.59% |
| 1999 Q1 | 7.3 Million USD | 124.25% |
| 1999 Q3 | 8.4 Million USD | 5.0% |
| 1998 FY | -15.2 Million USD | 27.96% |
| 1998 Q4 | -30.1 Million USD | -601.67% |
| 1998 Q3 | 6 Million USD | 17.65% |
| 1998 Q2 | 5.1 Million USD | 34.21% |
| 1998 Q1 | 3.8 Million USD | 222.58% |
| 1997 Q2 | -2.1 Million USD | -333.33% |
| 1997 Q1 | 900 Thousand USD | -90.22% |
| 1997 FY | -21.1 Million USD | -164.72% |
| 1997 Q4 | -3.1 Million USD | 81.66% |
| 1997 Q3 | -16.9 Million USD | -704.76% |
| 1996 Q3 | 8.6 Million USD | 8.86% |
| 1996 Q2 | 7.9 Million USD | 12.86% |
| 1996 Q1 | 7 Million USD | -1.41% |
| 1996 FY | 32.6 Million USD | 51.63% |
| 1996 Q4 | 9.2 Million USD | 6.98% |
| 1995 Q1 | 4 Million USD | -6.98% |
| 1995 FY | 21.5 Million USD | 61.65% |
| 1995 Q4 | 7.1 Million USD | 31.48% |
| 1995 Q2 | 4.9 Million USD | 22.5% |
| 1995 Q3 | 5.4 Million USD | 10.2% |
| 1994 Q4 | 4.3 Million USD | 19.44% |
| 1994 Q2 | 2.6 Million USD | -7.14% |
| 1994 Q3 | 3.6 Million USD | 38.46% |
| 1994 FY | 13.3 Million USD | 37.11% |
| 1994 Q1 | 2.8 Million USD | -24.32% |
| 1993 Q2 | 2.1 Million USD | 50.0% |
| 1993 FY | 9.7 Million USD | 97.96% |
| 1993 Q4 | 3.7 Million USD | 42.31% |
| 1993 Q1 | 1.4 Million USD | -17.65% |
| 1993 Q3 | 2.6 Million USD | 23.81% |
| 1992 Q3 | 1.5 Million USD | 25.0% |
| 1992 Q2 | 1.2 Million USD | 140.0% |
| 1992 Q1 | 500 Thousand USD | -61.54% |
| 1992 Q4 | 1.7 Million USD | 13.33% |
| 1992 FY | 4.9 Million USD | 53.13% |
| 1991 Q3 | 1 Million USD | 66.67% |
| 1991 FY | 3.2 Million USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q4 | 1.3 Million USD | 30.0% |
| 1991 Q2 | 600 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 717.337% |
| Accuray Incorporated | -15.54 Million USD | 5536.102% |
| Align Technology, Inc. | 445.05 Million USD | -89.874% |
| Elevance Health Inc. | 5.98 Billion USD | 85.885% |
| AxoGen, Inc. | -21.71 Million USD | 3991.334% |
| Boston Scientific Corporation | 1.59 Billion USD | 46.953% |
| CVS Health Corporation | 8.34 Billion USD | 89.872% |
| Cardinal Health, Inc. | 852 Million USD | 0.817% |
| Centene Corporation | 2.7 Billion USD | 68.725% |
| DaVita Inc. | 691.53 Million USD | -22.198% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 83.879% |
| Hologic, Inc. | 789.5 Million USD | -7.035% |
| Humana Inc. | 2.48 Billion USD | 66.049% |
| Laboratory Corporation of America Holdings | 418 Million USD | -102.163% |
| Masimo Corporation | 81.5 Million USD | -936.861% |
| McKesson Corporation | 3 Billion USD | 71.851% |
| Patterson Companies, Inc. | 185.93 Million USD | -354.492% |
| Quest Diagnostics Incorporated | 854 Million USD | 1.049% |
| ResMed Inc. | 1.02 Billion USD | 17.23% |
| Henry Schein, Inc. | 416 Million USD | -103.135% |
| Teladoc Health, Inc. | -220.36 Million USD | 483.469% |
| Universal Health Services, Inc. | 717.79 Million USD | -17.727% |
| Veeva Systems Inc. | 525.7 Million USD | -60.745% |
| Baxter International Inc. | 2.65 Billion USD | 68.184% |
| Becton, Dickinson and Company | 1.48 Billion USD | 43.056% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 53.001% |
| Danaher Corporation | 4.2 Billion USD | 79.88% |
| Stryker Corporation | 3.16 Billion USD | 73.3% |
| Medtronic plc | 3.67 Billion USD | 77.012% |